Optimal therapeutic positioning of a selective bi-steric inhibitor of MTORC1 in genetically defined cancers. (October 2020) - Jiang, J.; Yang, Y.C.; Schulze, C.J.; Evans, J.W.; Wang, Z.C.; Lee, B.J.; Choy, T.J.; Reyes, D.F.; Zhao, R.P.; Tao, J.Y.; Du, H.; Ozawa, T.; et al.